HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use KETAMINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for KETAMINE HYDROCHLORIDE INJECTION.
KETAMINE HYDROCHLORIDE injection, for intravenous or intramuscular use, CIII
Initial U.S. Approval: 1970
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
Ketamine Hydrochloride Injection is a general anesthetic indicated:
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Injection: 500 mg/10 mL (50 mg/mL) and 500 mg/5 mL (100 mg/mL) multiple-dose vials. (3)
WARNINGS AND PRECAUTIONS
The most common adverse reactions are emergence reactions and elevated blood pressure and pulse. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.